BACKGROUND: Mutations in the X-linked gene MED12 cause at least three different, but closely related, entities of syndromic intellectual disability. Recently, a new syndrome caused by MED13L deleterious variants has been described, which shows similar clinical manifestations including intellectual disability, hypotonia, and other congenital anomalies. METHODS: Genotyping of 1,256 genes related with neurodevelopment was performed by next-generation sequencing in three unrelated patients and their healthy parents. Clinically relevant findings were confirmed by conventional sequencing. RESULTS: Each patient showed one de novo variant not previously reported in the literature or databases. Two different missense variants were found in the MED12 or MED13L genes and one nonsense mutation was found in the MED13L gene. CONCLUSION: The phenotypic consequences of these mutations are closely related and/or have been previously reported in one or other gene. Additionally, MED12 and MED13L code for two closely related partners of the mediator kinase module. Consequently, we propose the concept of a common MED12/MED13L clinical spectrum, encompassing Opitz-Kaveggia syndrome, Lujan-Fryns syndrome, Ohdo syndrome, MED13L haploinsufficiency syndrome, and others.
BACKGROUND: Mutations in the X-linked gene MED12 cause at least three different, but closely related, entities of syndromic intellectual disability. Recently, a new syndrome caused by MED13L deleterious variants has been described, which shows similar clinical manifestations including intellectual disability, hypotonia, and other congenital anomalies. METHODS: Genotyping of 1,256 genes related with neurodevelopment was performed by next-generation sequencing in three unrelated patients and their healthy parents. Clinically relevant findings were confirmed by conventional sequencing. RESULTS: Each patient showed one de novo variant not previously reported in the literature or databases. Two different missense variants were found in the MED12 or MED13L genes and one nonsense mutation was found in the MED13L gene. CONCLUSION: The phenotypic consequences of these mutations are closely related and/or have been previously reported in one or other gene. Additionally, MED12 and MED13L code for two closely related partners of the mediator kinase module. Consequently, we propose the concept of a common MED12/MED13L clinical spectrum, encompassing Opitz-Kaveggia syndrome, Lujan-Fryns syndrome, Ohdo syndrome, MED13L haploinsufficiency syndrome, and others.
Authors: Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman Journal: Nature Date: 2014-06-04 Impact factor: 49.962
Authors: Julia Vodopiutz; Maria T Schmook; Vassiliki Konstantopoulou; Barbara Plecko; Susanne Greber-Platzer; Marc Creus; Rainer Seidl; Andreas R Janecke Journal: Eur J Pediatr Date: 2014-12-03 Impact factor: 3.183
Authors: M R Dotson; C X Yuan; R G Roeder; L C Myers; C M Gustafsson; Y W Jiang; Y Li; R D Kornberg; F J Asturias Journal: Proc Natl Acad Sci U S A Date: 2000-12-19 Impact factor: 11.205
Authors: Charles E Schwartz; Patrick S Tarpey; Herbert A Lubs; Alain Verloes; Melanie M May; Hiba Risheg; Michael J Friez; P Andrew Futreal; Sarah Edkins; Jon Teague; Sylvain Briault; Cindy Skinner; Astrid Bauer-Carlin; Richard J Simensen; Sumy M Joseph; Julie R Jones; Josef Gecz; Michael R Stratton; F Lucy Raymond; Roger E Stevenson Journal: J Med Genet Date: 2007-03-16 Impact factor: 6.318
Authors: T Smol; F Petit; A Piton; B Keren; D Sanlaville; A Afenjar; S Baker; E C Bedoukian; E J Bhoj; D Bonneau; E Boudry-Labis; S Bouquillon; O Boute-Benejean; R Caumes; N Chatron; C Colson; C Coubes; C Coutton; F Devillard; A Dieux-Coeslier; M Doco-Fenzy; L J Ewans; L Faivre; E Fassi; M Field; C Fournier; C Francannet; D Genevieve; I Giurgea; A Goldenberg; A K Green; A M Guerrot; D Heron; B Isidor; B A Keena; B L Krock; P Kuentz; E Lapi; N Le Meur; G Lesca; D Li; I Marey; C Mignot; C Nava; A Nesbitt; G Nicolas; C Roche-Lestienne; T Roscioli; V Satre; A Santani; M Stefanova; S Steinwall Larsen; P Saugier-Veber; S Picker-Minh; C Thuillier; A Verloes; G Vieville; M Wenzel; M Willems; S Whalen; Y A Zarate; A Ziegler; S Manouvrier-Hanu; V M Kalscheuer; B Gerard; Jamal Ghoumid Journal: Neurogenetics Date: 2018-03-06 Impact factor: 2.660
Authors: Naikhoba C O Munabi; Shady Mikhail; Omar Toubat; Michelle Webb; Allyn Auslander; Pedro A Sanchez-Lara; Zarko Manojlovic; Ryan J Schmidt; David Craig; William P Magee; Subramanyan Ram Kumar Journal: Am J Med Genet A Date: 2022-04-06 Impact factor: 2.578
Authors: Lot Snijders Blok; Susan M Hiatt; Kevin M Bowling; Jeremy W Prokop; Krysta L Engel; J Nicholas Cochran; E Martina Bebin; Emilia K Bijlsma; Claudia A L Ruivenkamp; Paulien Terhal; Marleen E H Simon; Rosemarie Smith; Jane A Hurst; Heather McLaughlin; Richard Person; Amy Crunk; Michael F Wangler; Haley Streff; Joseph D Symonds; Sameer M Zuberi; Katherine S Elliott; Victoria R Sanders; Abigail Masunga; Robert J Hopkin; Holly A Dubbs; Xilma R Ortiz-Gonzalez; Rolph Pfundt; Han G Brunner; Simon E Fisher; Tjitske Kleefstra; Gregory M Cooper Journal: Hum Genet Date: 2018-05-08 Impact factor: 4.132